Photobiomodulation at 830 nm Stimulates Migration, Survival and Proliferation of Fibroblast Cells
DOI: https://doi.org/10.2147/DMSO.S374649
2022-09-21
Abstract:Olajumoke Arinola Oyebode, Nicolette Nadene Houreld Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, Gauteng, South Africa Correspondence: Olajumoke Arinola Oyebode, Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, Gauteng, South Africa, Tel + 27781519058, Email Purpose: Photobiomodulation (PBM) promotes diabetic wound healing by favoring cell survival and proliferation. This study aimed to investigate the potential of PBM in stimulating cellular migration, viability, and proliferation using the transforming growth factor-β 1 (TGF-β 1)/Smad signaling pathway. Methods: The study explored the in vitro effects of near infrared (NIR) light on cell viability (survival) and proliferation as well as the presence of TGF-β 1, phosphorylated TGF‐β receptor type I (pTGF-βR1) and phosphorylated mothers against decapentaplegic‐homolog (Smad)‐2/3 (p-Smad2/3) in different fibroblast cell models. Results: Results show a significant increase in cellular migration in wounded models, and increased viability and proliferation in irradiated cells compared to their respective controls. An increase in the presence of TGF-β 1 in the culture media, a reduction in pTGF-βR1 and a slight presence of p-Smad2/3 was observed in the cells. Conclusion: These findings show that PBM at 830 nm using a fluence of 5 J/cm 2 could induce cell viability, migration and proliferation to favor successful healing of diabetic wounds. This study contributes to the growing body of knowledge on the molecular and cellular effect of PBM and showcases the suitability of PBM at 830 nm in managing diabetic wounds. Keywords: diabetic wound, photobiomodulation, wound healing, hyperglycemia, NIR light Globally, diabetes mellitus (DM), which was initially dubbed as a disease of the rich, is ravaging low- and middle-income populations. According to the 2021 International Diabetes Federation (IDF) report, 537 million adults are living with diabetes globally (75% of these adults live in low- and middle-income countries) and this figure is expected to increase to 643 million by 2030 and 753 million by 2045. 1 Africa has seen a significant increase in the incidence of DM, with an estimated 19.4 million adults living with diabetes (3.9% prevalence rate). 2 Unfortunately, the African region has the highest proportion of individuals living with diabetes who are unaware of their condition (approximately 54%; that is 1 in 2 persons). 1 There is a postulated increase of 129% in diabetic cases in Africa by the year 2045. 1 Data has suggested that this increase is connected to rapid demographic, sociocultural and economic transitions. 3 With an increase in diabetes comes a rise in micro- and macrovascular complications, which could negatively impact the health of diabetic patients. This together with neuropathy leads to further complications and an increase in the incidence of lower limb amputations due to non-healing diabetic foot ulcers (DFUs). 4 Globally, it is estimated that 25% of the diabetic patients develop a DFU, 5 with a high recurrence rate of up to 70% within 5 years, and with statistics showing that 85% of the amputations in diabetics starts with ulcers. 6,7 Diabetic foot amputation is one of the most common and most feared complication of diabetes. 8 In certain parts of the world, like the USA, over one billion dollars is spent annually on managing chronic diabetic wounds. 9 Under diabetic conditions, alterations in any stage of wound healing could lead to slow or non-healing of even the most minor wounds, particularly on the body's lower extremities. 10 Wound healing in healthy individuals usually occurs through four clear-cut phases: hemostasis, inflammation, proliferation, and maturation (remodeling). 11 However, in DM, the wound healing process typically ceases at the inflammatory phase, 12 probably due to hyperglycemia which causes glucose to clog up the arteries and impede blood circulation, induce hypoxia, and inhibit collagen production. 13,14 A hyperglycemia-induced increase in reactive oxygen species (ROS) further promotes diabetic complications by increasing oxidative stress which could lead to tissue damage, weakened skin, and slow wound contraction. 15,16 Growth factors, such as transforming growth factor beta (TGF-β) are involved in the process of wound closure through stimulation or inhibition of growth, proliferation and differentiation of fibroblast cells into myofibroblasts, thereby improving the formation of the extracellular matrix (ECM). 17 TGF-β together with its receptor and Smad constitute the TGF-β/ -Abstract Truncated-